Concomitant ATTR and AL Cardiac Amyloidosis With Matching 99mTc-DPD Scintigraphy and 18F-Flutemetamol PET/CT

Joo O. Hyun, Jong Chan Youn, Eun Ji Han, Mi Hyang Jung, Jung Yeon Lee, Sung Soo Park, Yeoun Eun Sung, Chang Ki Min

Research output: Contribution to journalArticlepeer-review

Abstract

Two distinct types of systemic amyloidosis—transthyretin (ATTR) and light chain (AL)—account for the majority of cardiac amyloidosis (CA), which have been considered mutually exclusive. Diagnostic confusion can arise when both proteins are identified from an amyloid deposit. We present a rare occurrence of histopathologically confirmed concomitant ATTR and AL CA captured on 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) scan and 18F-flutemetamol (FMM) PET/CT.

Original languageEnglish
Pages (from-to)460-461
Number of pages2
JournalClinical Nuclear Medicine
Volume50
Issue number5
DOIs
StatePublished - 1 May 2025

Bibliographical note

Publisher Copyright:
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

Keywords

  • F-flutemetamol
  • amyloid PET
  • amyloidosis
  • concomitant
  • light chain
  • transthyretin

Fingerprint

Dive into the research topics of 'Concomitant ATTR and AL Cardiac Amyloidosis With Matching 99mTc-DPD Scintigraphy and 18F-Flutemetamol PET/CT'. Together they form a unique fingerprint.

Cite this